ConductScience.org, home

Trial · NCT07882602

Effect of Buzzy and Virtual Reality on Children Undergoing Venous Procedures

NCT07882602, Not applicable, Recruiting, Bandırma Onyedi Eylül University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Effect of Buzzy and Virtual Reality on Children Undergoing Venous Procedures. Trials, record NCT07882602. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07882602

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Effect of Buzzy and Virtual Reality on Children Undergoing Venous Procedures
NCT number
NCT07882602
Status
Recruiting
Phases
Not applicable
Enrollment
105 participants, estimated
Lead sponsor
Bandırma Onyedi Eylül University
Conditions
Fever, Children
Interventions
Vein-imaging device + virtual reality headset group, Vein-imaging device + Buzzy group
First posted
2026-10-20
Last updated
2026-10-20

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryWong-Baker FACES Pain Rating Scale3 minutes before the procedure and 3 minutes after the procedure
The Wong-Baker FACES Pain Rating Scale, used to assess pain in this study, was first developed by Donna Wong and Connie Morain Baker in 1981 and revised in 1983. It is a visually based instrument, widely used worldwide, for assessing pain intensity in children aged three years and older, and it allows children to express themselves through facial expressions. The scale consists of six different facial expressions: the smiling face on the far left represents no pain (a score of 0), whereas the crying face on the far right represents severe pain (a score of 10). When administering the scale, the meaning of each face is explained to the child, and the child is asked to select the face that best represents how they feel. The scale has frequently been used in similar studies conducted in Türkiye (Erdoğan \& Aytekin Özdemir, 2021; Gerçeker et al., 2018). An email requesting permission was sent to the official website of the Wong-Baker FACES Foundation, and the Turkish version of the scale an
PrimaryChildren's Fear and Anxiety Scale (CFAS)3 minutes before the procedure and 3 minutes after the procedure
Developed by McMurtry and colleagues in 2011, this scale was designed to assess children's levels of fear and anxiety. Its validity and reliability in Turkish were established by Gerçeker et al. (2018). The scale is administered by presenting children with a visual display containing five different facial expressions that can be rated on a scale from 0 to 4. Each facial expression represents a specific emotional state. The assessment can be conducted by researchers or parents to determine levels of fear and anxiety both before and during a procedure. On the scale, a score of "0" indicates that the child experiences no fear or anxiety, while a score of "4" represents the highest level of fear and anxiety (Gerçeker et al., 2018; Akdemir, 2019; Akan, 2024). Since the Child Fear and Anxiety Scale is a sum-scored instrument, item-total correlations and the Cronbach's alpha coefficient could not be calculated.
PrimarySTAI State-Trait Anxiety Inventory3 minutes before the procedure and 3 minutes after the procedure
The State-Trait Anxiety Inventory (STAI), developed by Spielberger et al. (1970) to assess anxiety as both a temporary state and an enduring trait, was adapted into Turkish, with validity and reliability established, by Öner and Le Compte (1998). It comprises two 20-item subscales, state and trait. Items are rated on a four-point Likert scale; total scores range from 20 to 80, with higher scores indicating greater anxiety (Fırat, 2016; Kaçmaz, 2024). Scores below 36 indicate no anxiety, 37-42 mild anxiety, and 42 or above high anxiety (Yurdaor et al., 2022). For the Turkish version, Kuder-Richardson alpha coefficients ranged from 0.83 to 0.87 (trait) and 0.94 to 0.96 (state); item-remainder correlations from 0.34 to 0.72 (trait) and 0.42 to 0.85 (state); test-retest coefficients from 0.71 to 0.86 (trait) and 0.26 to 0.68 (state). The state subscale, a validated measure, will be used to assess parental anxiety (Fırat, 2016; Kaçmaz, 2024; Yurdaor et al., 2022).

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07882602

GET https://conductscience.org/api/trials/v1/NCT07882602/registered